SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-024882
Filing Date
2021-05-06
Accepted
2021-05-06 16:01:13
Documents
39
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_pluristemthera.htm 10-Q 395860
2 CERTIFICATION f10q0321ex31-1_pluristem.htm EX-31.1 10112
3 CERTIFICATION f10q0321ex31-2_pluristem.htm EX-31.2 10187
4 CERTIFICATION f10q0321ex32-1_pluristem.htm EX-32.1 4300
5 CERTIFICATION f10q0321ex32-2_pluristem.htm EX-32.2 4299
  Complete submission text file 0001213900-21-024882.txt   2429843

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE psti-20210331.xml EX-101.INS 328632
7 XBRL SCHEMA FILE psti-20210331.xsd EX-101.SCH 36875
8 XBRL CALCULATION FILE psti-20210331_cal.xml EX-101.CAL 25807
9 XBRL DEFINITION FILE psti-20210331_def.xml EX-101.DEF 174112
10 XBRL LABEL FILE psti-20210331_lab.xml EX-101.LAB 316647
11 XBRL PRESENTATION FILE psti-20210331_pre.xml EX-101.PRE 172095
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 21897567
SIC: 2836 Biological Products, (No Diagnostic Substances)